About Enhancer
| Enhancer ID: | E_02881 |
| Species: | Homo sapiens |
| Position : | chr2:20850000-20880000   |
| Year: | 2016 |
| Title: | Chromatin interactions and candidate genes at ten prostate cancer risk loci. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | prostate cancer |
| PMID: | 26979803 |
| MONDO: | MONDO:0008315 |
| Tissue: | prostate gland |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | LNCaP |
| CVCL ID: | CVCL_0395 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Chromatin interaction assay, Gene expression assay; Chromatin interaction assay; Disease-variant functional analysis |
| High Throughput Method: | Capture 3C-seq, RNA-seq, SNP genotyping array; eQTL analysis; GWAS |
| Low Throughput Method: | RT-qPCR; 3C |
About Target Gene
| Target gene : | LDAH |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
5 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02882 | chr2:20850000-20880000 | prostate gland | malignant cell | prostate cancer |
| E_02917 | chr2:20850000-20880000 | prostate gland | NA | NA |
| E_02918 | chr2:20850000-20880000 | blood | NA | NA |
| E_02919 | chr2:20850000-20880000 | blood | NA | NA |
| E_02920 | chr2:20850000-20880000 | prostate gland | NA | NA |
Expression of Target Genes for the Enhancer